|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 38/13 | |||
| A61K 39/395 | |||
| A61K 45/06 | |||
| A61P 37/06 |
| (11) | Number of the document | 2683406 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12758099.1 |
| Date of filing the European patent application | 2012-03-12 | |
| (97) | Date of publication of the European application | 2014-01-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/028782 |
| Date | 2012-03-12 |
| (87) | Number | WO 2012/125569 |
| Date | 2012-09-20 |
| (30) | Number | Date | Country code |
| 201161451870 P | 2011-03-11 | US |
| (72) |
REIMANN, Keith, A., US
WANG, Rijian, US
LARSEN, Christian, P., US
|
| (73) |
Beth Israel Deaconess Medical Center, Inc.,
330 Brookline Avenue, Boston, MA 02215,
US
Emory University, Office of Technology Transfer 1599 Clifton Rd. NE, Atlanta, GA 30322, US |
| (54) | ANTI-CD40 ANTIBODIES AND USES THEREOF |
| ANTI-CD40 ANTIBODIES AND USES THEREOF |